Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Centelles – page 32

3 673 clinical trials in Centelles, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Centelles at a glance
3 673
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 673 trials in Centelles

Open in trial search

Endometrial cancer+12

Recruiting

A study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

A study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Potassium Chloride
  • Sponsor:Dyne Therapeutics Inc.

A study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Clemizole Hydrochloride
  • Sponsor:Epygenix Therapeutics Inc.

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:IKT-001PRO
  • Sponsor:Inhibikase Therapeutics Inc.

A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

Investigational
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Ovarian cancer

Recruiting

A study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic vein tissue segment, decellularised, with a functional valve perfused with autologous peripheral blood
  • Sponsor:VeriGraft AB

A study to evaluate the safety of MRM-3379 in men with Fragile X Syndrome

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:MRM-3379
  • Sponsor:Mirum Pharmaceuticals Inc.

A study of daraxonrasib (RMC-6236) compared to observation in patients with resected pancreatic cancer following chemotherapy

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Daraxonrasib
  • Sponsor:Revolution Medicines Inc.

Study of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Novartis Pharma AG

A study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

Homocystinuria

Recruiting

A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pegtibatinase
  • Sponsor:Travere Therapeutics Inc.

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Centelles

What the registry says about research in the country

01 Infectious Disease Prevention

Comprehensive research focusing on viral infections including studies evaluating vaccines against SARS-CoV-2, Herpes Zoster, and Cytomegalovirus. Multiple trials are examining vaccine efficacy and immune response in different age groups.

  • COVID-19 Vaccine Development
  • Viral Disease Prevention
  • Vaccine Safety Studies

Special attention is given to vaccine co-administration studies and booster dose evaluations in various populations.

02 Respiratory Health

Innovative clinical research examining treatments for respiratory conditions, including studies on RSV vaccines for older adults and asthma medication delivery systems. These trials aim to enhance treatment options for respiratory diseases.

  • RSV Prevention
  • Asthma Management
  • Pneumococcal Disease

Focus on developing effective preventive measures and treatments for respiratory infections.

03 Cardiovascular Health

Advanced research into cardiovascular disease prevention and treatment, with emphasis on managing hypercholesterolemia and reducing major adverse cardiovascular events. Studies evaluate new therapeutic approaches for heart health.

  • Cholesterol Management
  • Cardiovascular Risk Reduction
  • Preventive Cardiology

Trials focus on innovative medications and preventive strategies for cardiovascular health improvement.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.